Cherry Tree Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Cherry Tree Wealth Management's BMY Position: Q1 2026 in Review
Cherry Tree Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 800 shares — an estimated $43.2K sold.
Cherry Tree Wealth Management first reported a position in BMY in Q2 2023 and held it in 11 quarters. The position peaked at $66.6K in Q2 2023. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Cherry Tree Wealth Management reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
- Cherry Tree Wealth Management sold 800 Bristol-Myers Squibb shares in Q1 2026, an estimated $43.2K.
- Cherry Tree Wealth Management first reported a position in Bristol-Myers Squibb in Q2 2023 and held it in 11 quarters.
- Cherry Tree Wealth Management's Bristol-Myers Squibb position peaked at $66.6K in Q2 2023.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Cherry Tree Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.